Clinical Trial Update: A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating abatacept in Chinese patients with active rheumatoid arthritis who had an inadequate response to methotrexate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis (RA) | Phase 3 | Status: UNKNOWN